In this interview, Stephen J. Nicholls and Sotirios Tsimikas
discuss AKCEA: Safety and Efficacy of AKCEA-APO(a)-to Lower
Lipoprotein(a) Levels in Patients with Established Cardiovascular
Disease: A Phase 2 Dose-Ranging Trial.
About the Podcast
The American College of Cardiology offers select interviews and summaries of cardiology’s most interesting research areas from ACCEL’s renowned library, hosted by ACCEL Editor-in-Chief Alison L. Bailey, MD, FACC, FAACPVR.